IMUX

Immunic, Inc. is a biotechnology company focused on developing oral therapies for neurologic diseases. It specializes in small molecule programs aimed at addressing chronic inflammatory and autoimmune diseases. The company is developing treatments for conditions such as multiple sclerosis and celiac disease, with an emphasis on safety and tolerability for patients.